Growth: Global Biosimilar Market to Generate $83,836.4 Million and Exhibit a CAGR of 24.9% from 2021 to 2028 [170-Pages] | Report by Research Dive

Market Dynamics Market Dynamics The demand for biosimilar drugs is increasing across the globe due to their cost-effectiveness. Government and government bodies are highly supporting in the development as well as approval of biosimilars. For instance, inJuly 2021, the US Food & Drug Administration (FDA) approved the biosimilar insulin product for type-1 and type-2 diabetes. All these factors are estimated to propel the growth of the global biosimilar market during the forecast...
Comunicato Precedente

next
Comunicato Successivo

next

Market Dynamics

The demand for biosimilar drugs is increasing across the globe due to their cost-effectiveness. Government and government bodies are highly supporting in the development as well as approval of biosimilars. For instance, in July 2021, the US Food & Drug Administration (FDA) approved the biosimilar insulin product for type-1 and type-2 diabetes. All these factors are estimated to propel the growth of the global biosimilar market during the forecast period. Moreover, ongoing research on new biosimilars and the patent expiry of biologics are estimated to create massive growth opportunities for the global market by 2028. However, the high costs of biosimilars and the complexities in manufacturing are expected to hamper the market growth during the estimated timeframe.

Download Free Sample to explore growth opportunities in the Global Biosimilar Market

Impact of COVID-19 Pandemic on the Market

The COVID-19 pandemic has negatively impacted the global biosimilar market growth. This is majorly owing to the disruption in manufacturing capacity and supply chain during the pandemic period. Besides, pharma companies are facing challenges in the development of biosimilar and the FDA approvals are reduced for non-COVID therapeutics owing to the pandemic. All these factors have unfavorably impacted the global biosimilar market growth during the period of crisis.

Check Out How COVID-19 Impacts Global Biosimilar Market at $2999

Key Segment Findings of the Market:

The research report segments the global market into product type, application, and region.

Request On-demand Customized research of Biosimilar Market Report

Growth: Global Biosimilar Market to Generate $83,836.4 Million and Exhibit a CAGR of 24.9% from 2021 to 2028 [170-Pages] | Report by Research Dive

Prominent Market Players

The key players of the global market include

These players are focusing on product launches, technological advancements, and strategic collaborations to gain a competitive in the global market.

For instance, in April 2021, Novartis AG (Sandoz), a global healthcare company, signed an agreement with a leading commercial-stage biopharmaceutical company, Bio-Thera Solutions (China) in order to commercialize BAT1706 biosimilar in the US, Canada, Europe, and other international markets.

More about Biosimilar Market:

Related Top Trending Report Links:

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact:
Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York NY 10005
(P) +91-(788)-802-9103 (India)
Toll Free: 1-888-961-4454
E-mail: [email protected] 
Website: https://www.researchdive.com
Blog: https://www.researchdive.com/blog/
LinkedIn: https://www.linkedin.com/company/research-dive/
Twitter: https://twitter.com/ResearchDive
Facebook: https://www.facebook.com/Research-Dive-1385542314927521

Logo: https://mma.prnewswire.com/media/997523/Research_Dive_Logo.jpg 

Ufficio Stampa

 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom

Allegati
Slide ShowSlide Show
Non disponibili
;